Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7%

Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7%

Eton Pharmaceuticals Q4 GAAP EPS of $0.05 missed the $0.20 estimate by 75%, though revenue of $21.3M topped consensus and…

Canadian Solar 2025 Financial Review

Canadian Solar reports Q4 loss of $1.66/share, 84.5% wider than estimates, as revenue of $1.20B misses consensus by $150M.

Intellicheck (IDN) EPS Soars 114.5% to $0.08, Crushing $0.03 Estimate on Revenue Growth

Intellicheck posts $0.08 EPS vs $0.03 estimate, revenue up 12% YoY to $6.6M as profitability inflection gains momentum.

Arcos Dorados 2025 Financial Review

Arcos Dorados Q4 EPS of $0.13 missed estimates by 35.7% despite revenue topping consensus at $1.27 billion, up 10.7% year-over-year.

LexinFintech Holdings Ltd. 2025 Financial Review

LexinFintech posts $1.38 adjusted EPS for Q4 2025, matching prior quarter as shares trade near 52-week lows.

Movado Group FY 2026 Financial Results

Movado Group posts Q4 EPS of $0.57, beating the $0.54 estimate by 5.6%, as revenue of $191.6M tops consensus by…

Caleres Q4 & FY25 Financial Review

Caleres posts $0.38 EPS, beating estimates by 55.5% as margins hold despite sequential revenue decline to $639.2M.

GrowGeneration 2025 Financial Results Breakdown

GrowGeneration posts wider-than-expected Q4 loss of $0.12 per share despite revenue topping estimates at $37.8M.

Torrid Holdings Inc.: Fiscal 2025 Financial Review

Torrid narrows Q4 loss to $0.06 per share vs $0.07 estimate; revenue of $236.2M tops consensus by 2.2% despite balance…

Greystone Housing Impact Investors LP 2025 Financial Review

Greystone Housing posts $0.17 loss vs $0.60 estimate as Q4 revenue of $17.2M misses consensus by 27.5%, shares near 52-week…